Erasca

Filed a patent for "jak inhibitor with erk1/2 and/or shp2 inhibitors combination therapy" on Fri, March 15, 2024

Filed a patent for "raf inhibitor and erk1/2 and/or shp2 inhibitor combination therapy" on Fri, January 6, 2023

Filed a patent for "raf inhibitor and kras g12c inhibitor combination therapy" on Fri, January 6, 2023

Filed a patent for "kras inhibitors" on Fri, February 17, 2023

Filed a patent for "thiophene ulk1/2 inhibitors and their use thereof" on Thu, May 4, 2023

Filed a patent for "macrocyclic ulk1/2 inhibitors and their use thereof" on Wed, May 10, 2023

Filed a patent for "thiophene ulk1/2 inhibitors and their use thereof" on Wed, May 17, 2023

Filed a patent for "raf inhibitor and erk1/2 and/or shp2 inhibitor combination therapy" on Thu, June 1, 2023

Filed a patent for "raf inhibitor and kras g12c inhibitor combination therapy" on Thu, June 1, 2023

Filed a patent for "kras inhibitors" on Thu, October 26, 2023

Filed a patent for "kras inhibitors" on Fri, November 17, 2023

Filed a patent for "kras inhibitors" on Wed, December 27, 2023

Filed a patent for "thiophene ulk1/2 inhibitors and their use thereof" on Thu, May 9, 2024

Filed a patent for "uses of tri-substituted heteroaryl derivatives as src homology-2 phosphatase inhibitors" on Thu, April 4, 2024

Filed a patent for "egfr inhibitor polymorph forms" on Thu, August 29, 2024

Filed a patent for "antibodies against egfr and their uses" on Thu, December 21, 2023

Filed a patent for "erk1/2 inhibitor polymorph forms" on Tue, September 20, 2022

Filed a patent for "kras inhibitor conjugates" on Thu, October 6, 2022

Filed a patent for "kras inhibitor conjugates" on Tue, October 18, 2022

Filed a patent for "thiophene ulk1/2 inhibitors and their use thereof" on Thu, November 10, 2022

Filed a patent for "kras inhibitor conjugates" on Tue, November 29, 2022

Filed a patent for "tricyclic pyridones and pyrimidones" on Thu, May 25, 2023

Filed a patent for "kras inhibitor conjugates" on Wed, December 14, 2022

Filed a patent for "kras inhibitor conjugates" on Thu, January 26, 2023

Filed a patent for "combination therapies for the treatment of cancer" on Thu, February 22, 2024